Investors don’t always react the way you’d expect to the news. We decipher the often manic-depressive behavior of Wall Street. Read More

The FDA approved Biogen's Alzheimer's drug. That's great news for Biogen and its shareholders, but it's also fantastic news for a competitor. Read More

Cash on corporate balance sheets in the second quarter has reached an all-time high. Here’s why that’s a powerful bullish factor. Read More

Establishing an emergency fund is one of the core principals of personal finance. We discuss the options in creating one. Read More

The COVID variant is wreaking havoc in under-vaccinated hot spots, but the financial markets continue to hit new highs. Read More

The company formerly known as Weight Watchers lost nearly a quarter of its value last Wednesday after releasing its fiscal 2021 Q2 results. Read More

U.S. stocks hover at all-time highs but the markets face a litany of risks, chief among them COVID Delta. Here’s how to protect your assets. Read More

Recent economic data present mixed news. Here’s an asset that provides both growth potential and a hedge under these conflicting conditions. Read More

This week, a special purpose acquisition company (SPAC) mega-merger was announced in the cannabis sector. Investors should remain wary. Read More

For the first time since 2017, all regions of the world economy are generally growing in tandem, a remarkable comeback from the COVID crash. Read More